jackdow 200 ec
goldengrass ltd. guithavon street, cm8 1bj witham, essex, anglia - fluroksypyr-meptyl - 200 g - chwastobójczy
jay 250 sc
goldengrass ltd. guithavon street, cm8 1bj witham, essex, anglia - azoksystrobina - 250 g - fungicyd
rook 480 ec
goldengrass ltd. guithavon street, cm8 1bj witham, essex, anglia - chloropiryfos - 480 g - insektycyd
triben x 500 sg
goldengrass ltd. guithavon street, cm8 1bj witham, essex, anglia - tribenuron metylu - 50 % - chwastobójczy
vectis 240 sc
goldengrass ltd. guithavon street, cm8 1bj witham, essex, anglia - nikosulfuron - 240 g - chwastobójczy
yellow hammer 330 ec
goldengrass ltd. guithavon street, cm8 1bj witham, essex, anglia - pendimetalina - 330 g - chwastobójczy
zatem 500 sc
goldengrass ltd. guithavon street, cm8 1bj witham, essex, anglia - metazachlor - 500 g - chwastobójczy
ontozry
angelini pharma s.p.a - cenobamate - padaczka - przeciwpadaczkowe narzędzia, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.
onureg
bristol-myers squibb pharma eeig - azacytydyna - białaczka, szpikowe, ostre - Środki przeciwnowotworowe - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).
sitagliptin sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetes mellitus, type 2 - leki stosowane w cukrzycy - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.